Dr. Rishi Chadha, MD is a board‑certified gastroenterologist who specializes in preventive gastroenterology, colorectal cancer screening, and minimally invasive endoscopic procedures. He completed his fellowship at Sunrise Health GME in Las Vegas and previously trained in internal medicine at St. Vincent’s Medical Center in Connecticut.
Neuroendocrine tumors (NETs) are rare growths that start in cells that make hormones. These tumors can form in the stomach, pancreas, or intestines. Some NETs make too many hormones, which can cause different symptoms.
He reviews your personal and family history, including any genetic conditions like MEN1, lifestyle factors, and previous GI or pancreatic issues. A hands-on exam checks for abdominal tenderness, masses, or signs of hormone imbalance.
Specialized panels measure hormone levels'such as serotonin, gastrin, insulin, and cortisol-in blood or 24-hour urine samples to detect overproduction that may indicate a NET.
An endoscope is used to visually inspect the GI tract and retrieve a small tissue sample. Pathology confirms NET type and grade, guiding targeted therapy decisions.
Findings are discussed with a team of oncologists, radiologists, and endocrinologists to finalize an accurate diagnosis and personalized treatment plan.
Dr. Rishi Chadha, MD is a board‑certified gastroenterologist who specializes in preventive gastroenterology, colorectal cancer screening, and minimally invasive endoscopic procedures. He completed his fellowship at Sunrise Health GME in Las Vegas and previously trained in internal medicine at St. Vincent’s Medical Center in Connecticut.
Neuroendocrine tumors (NETs) are rare growths that start in hormone-producing cells, commonly found in the stomach, pancreas, intestines, or lungs.
Dr. Chadha uses a combination of blood and urine tests to check hormone levels, imaging studies (CT, MRI, PET scans), and sometimes an endoscopic biopsy to confirm the diagnosis.
Symptoms vary by tumor location and hormone secretion but often include facial flushing, frequent diarrhea, abdominal pain or bloating, wheezing, and unexplained weight loss.
The most common types include carcinoid tumors (often in the gut or lungs) and pancreatic neuroendocrine tumors (pNETs).
Yes. Advanced NETs can be managed with options such as Peptide Receptor Radionuclide Therapy (PRRT), targeted medications, symptom-relief therapies, and supportive care.
Treatment may involve lifestyle and dietary changes, somatostatin analogs, targeted therapies, acid reducers, anti-diarrheal and pain medications, minimally invasive procedures, surgery, or PRRT, depending on tumor type and stage.
Recovery from laparoscopic removal is typically quick; most patients feel better within 1-2 weeks.
Some NETs are linked to genetic conditions like MEN1, and having a family history of NETs can increase risk.
Yes. Eating small, low-fat meals, avoiding caffeine and alcohol, adding fiber, and staying well hydrated can help manage symptoms and improve digestion.
Follow-up visits are usually scheduled every 3-6 months, depending on your condition, treatment plan, and how well you're doing.
